Peter Johnson

Peter C. Johnson, MD is a University of Notre Dame and SUNY Upstate Medical University graduate. After General and Plastic Surgery training, Dr. Johnson practiced reconstructive surgery for ten years at the University of Pittsburgh where he founded and was the first President of the Pittsburgh Tissue Engineering Initiative. Subsequent roles were co-founder/CEO of Tissue Informatics, EVP of Life Sciences, CMO and CBO of Icoria, EVP, Entegrion, Inc. and VP, Research and Development and Medical and Scientific Affairs of Vancive Medical Technologies, an Avery Dennison business. He presently serves as President and CEO of Scintellix, LLC and Co-Founding Principal of MedSurgPI, LLC as well as acting CEO of Beacon Biotherapeutics and Chief Medical Officer of Microcures, Inc. and Praetego, Inc. He has Chaired the Plastic Surgery Research Council, was President of the Pennsylvania Biotechnology Association and the Tissue Engineering Society, International and sits on the Industrial Advisory Board of the UNC/NC State Joint Program in Bioengineering the Industrial Technology Advisory Board of the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center, the Board of the North Carolina Tissue Engineering and Regenerative Medicine Society, the Board of the Siegel Rare Neuroimmune Association, the Board of Plakous Therapeutics, Inc., the Board of Opsepio Therapeutics, Inc. and is Chairman of the Advisory Board for SonoVol, LLC and Chairman of the Board at CellX Technologies. He is an Adjunct Professor of Biomedical Engineering at the University of North Carolina at Chapel Hill, of Biomedical Engineering at NC State University and Duke University and of Regenerative Medicine at Wake Forest University School of Medicine.

Education

• MD State University of New York Upstate Medical University (1976 — 1980)
• BS University of Notre Dame (1972 — 1976)
• High School Diploma Canisius HS (1968 — 1972)

Companies

• Board Member Apie Therapeutics, Inc. (2020)
• Board Member Oxford Center for the Arts (2020)
• Chairman Of The Board CellX Technologies (2020)
• At-Large Board Member, Granville-Vance (NC) District Board of Health GRANVILLE-VANCE DISTRICT HEALTH DEPARTMENT - VANCE COUNTY (2020)
• Board Member/Secretary Opsepio Therapeutics, Inc. (2019)
• Adjunct Professor of Biomedical Engineering Duke University (2017)
• Member, Industrial Technology Advisory Board Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center (2017)
• Chairman, Board of Advisors Sonovol, LLC (2017)
• Proprietor Lark Farm (2015)